Skip to main content
John Kuo, MD, Neurosurgery, Austin, TX

JohnShu ShinKuoMDPhD FAANS FACS(He/Him)

Neurosurgery Austin, TX

Brain & Spinal Tumor, Pituitary Surgery, Stereotactic & Functional Neurosurgery

Vice President, China Medical University (Taiwan), Chair Professor, China Medical University (Taiwan); Yu Shan Scholar (Taiwan); Professor, Dept. of Neurosurgery, University of Texas at Austin

Dr. Kuo is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Kuo's full profile

Already have an account?


  • Dr. John Kuo is a board-certified neurosurgeon-scientist who serves as Vice President of Medical Affairs and Chair Professor at China Medical University in Taichung, Taiwan. He is a senior leader at this top private university composed of 10 colleges and schools, over 7000 students and trainees, and an integrated academic health system of major hospitals and clinics with over 6000 beds across Taiwan.

    He also is a Professor and served as the past-Inaugural Chair of the Dept. of Neurosurgery at Dell Medical School of The University of Texas at Austin. He received his MD from Harvard Medical School, PhD degree from MIT. He specializes in surgery for brain tumors, pituitary tumors, stereotactic radiosurgery for brain tumors, brain metastases and trigeminal neuralgia, and clinical management of complex brain tumor conditions. Dr. Kuo leads a research group that studies cancer stem cell biology, developing new cancer diagnostics and therapeutics, and leading clinical trials of new cancer agents. at UT Austin, he started a department of neurosurgeons and scientists dedicated to advancing the clinical care, full spectrum research and educational frontiers for children and adults with brain and spine diseases via new surgical techniques and devices, novel biological and immunotherapies, biomedical sciences and engineering new technologies in multidisciplinary teams focused on advancing brain-computer interface, neurorehabilitation, brain and spine trauma, cerebrovascular/stroke and brain tumor translational research groups. He was also Surgical director and helped lead the UT Mulva Clinic for the Neurosciences, an interdisciplinary enterprise of Neurosurgery, Neurology, Psychiatry, and Basic Neurosciences focused on improving outcomes for patients with neurological disorders.

Education & Training

  • University of Southern California/LAC+USC Medical Center
    University of Southern California/LAC+USC Medical CenterResidency, Neurological Surgery, 1998 - 2005
  • University of Southern California/LACUSC Medical Center
    University of Southern California/LACUSC Medical CenterFellowship, Stereotactic Radiosurgery, 2002 - 2003
  • Harvard Medical School
    Harvard Medical SchoolClass of 1998

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 1999 - 2025
  • TX State Medical License
    TX State Medical License 2018 - 2024
  • WI State Medical License
    WI State Medical License 2005 - 2019
  • American Board of Neurological Surgery Neurological Surgery

Awards, Honors, & Recognition

  • Top Doctors Austin Monthly, 2020-2022
  • America's Top Doctors Castle Connolly, 2012-2022
  • Fellow (FAANS) American Association of Neurological Surgeons
  • Join now to see all

Clinical Trials

Publications & Presentations


Journal Articles

  • Potential CAR T Cell Immunotherapy Against Diffuse Midline Gliomas  
    John Kuo, MD, Neurosurgery

Press Mentions

  • UW Study Uses 'Bio-Panning' to Find Human Antibodies for Brain Cancer Stem Cells
    UW Study Uses 'Bio-Panning' to Find Human Antibodies for Brain Cancer Stem CellsNovember 27th, 2017
  • Coming Soon: Glow-in-the-Dark Cancer Surgery
    Coming Soon: Glow-in-the-Dark Cancer SurgeryJanuary 20th, 2017
  • Tumor-Targeting Agent Attaches to Cancer Cells: Study - US News
    Tumor-Targeting Agent Attaches to Cancer Cells: Study - US NewsJune 11th, 2014
  • Join now to see all


  • Executive Committee, AANS/CNS Joint Section on Tumors 2013 - Present
  • Member, AANS Digital Content Committee 2020 - 2022
  • Co-Chair, UW Madison Biological Sciences Executive Committee 2017 - 2018
  • Chair, AANS Memberships Committee 2015 - 2018

Professional Memberships